These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
4. Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. Vaglini F; Pardini C; Viaggi C; Bartoli C; Dinucci D; Corsini GU J Neurochem; 2004 Oct; 91(2):285-98. PubMed ID: 15447662 [TBL] [Abstract][Full Text] [Related]
5. Neurochemical and toxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridine to rat serotonin neurons in dissociated cell cultures. Friedman LK; Mytilineou C J Pharmacol Exp Ther; 1990 May; 253(2):892-8. PubMed ID: 2338661 [TBL] [Abstract][Full Text] [Related]
7. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro. Chen LJ; Gao YQ; Li XJ; Shen DH; Sun FY J Pineal Res; 2005 Aug; 39(1):34-42. PubMed ID: 15978055 [TBL] [Abstract][Full Text] [Related]
8. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline. Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878 [TBL] [Abstract][Full Text] [Related]
9. The MPTP mouse model: cues on DA release and neural stem cell restorative role. Serra PA; Pluchino S; Marchetti B; Desole MS; Miele E Parkinsonism Relat Disord; 2008; 14 Suppl 2():S189-93. PubMed ID: 18579428 [TBL] [Abstract][Full Text] [Related]
10. Fucoidan protects against dopaminergic neuron death in vivo and in vitro. Luo D; Zhang Q; Wang H; Cui Y; Sun Z; Yang J; Zheng Y; Jia J; Yu F; Wang X; Wang X Eur J Pharmacol; 2009 Sep; 617(1-3):33-40. PubMed ID: 19545563 [TBL] [Abstract][Full Text] [Related]
11. Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity. Liang Y; Li S; Guo Q; Zhang Y; Wen C; Zou Q; Su B Brain Res; 2007 Oct; 1178():132-40. PubMed ID: 17900537 [TBL] [Abstract][Full Text] [Related]
12. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content. Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546 [TBL] [Abstract][Full Text] [Related]
13. Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions. Gibrat C; Saint-Pierre M; Bousquet M; Lévesque D; Rouillard C; Cicchetti F J Neurochem; 2009 Jun; 109(5):1469-82. PubMed ID: 19457163 [TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of MPP+-treated MN9D cells: a mechanism of toxicity study. Wang J; Xu Z; Fang H; Duhart HM; Patterson TA; Ali SF Neurotoxicology; 2007 Sep; 28(5):979-87. PubMed ID: 17475336 [TBL] [Abstract][Full Text] [Related]
15. A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. Kawasaki T; Ago Y; Kitao T; Nashida T; Takagi A; Takuma K; Matsuda T Neuropharmacology; 2008 Oct; 55(5):654-60. PubMed ID: 18573265 [TBL] [Abstract][Full Text] [Related]
16. MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration. Wang T; Pei Z; Zhang W; Liu B; Langenbach R; Lee C; Wilson B; Reece JM; Miller DS; Hong JS FASEB J; 2005 Jul; 19(9):1134-6. PubMed ID: 15845609 [TBL] [Abstract][Full Text] [Related]
17. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse. Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908 [TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity. Viaggi C; Pardini C; Vaglini F; Corsini GU J Neural Transm Suppl; 2006; (70):173-6. PubMed ID: 17017526 [TBL] [Abstract][Full Text] [Related]
19. Acute toxicity of MPTP and MPP(+) in the brain of embryo and newborn mice. Sai T; Uchida K; Nakayama H Exp Toxicol Pathol; 2013 Jan; 65(1-2):113-9. PubMed ID: 21798732 [TBL] [Abstract][Full Text] [Related]
20. MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. Sallinen V; Torkko V; Sundvik M; Reenilä I; Khrustalyov D; Kaslin J; Panula P J Neurochem; 2009 Feb; 108(3):719-31. PubMed ID: 19046410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]